Angiosarcomas are mesenchymal neoplasms of vascular origin that represent approximately 2% of soft tissue sarcomas. We discuss the case of a 75-year-old female who had presented with a purple nodular rash along the bilateral nasolabial folds. Upon further work-up, she was diagnosed with angiosarcoma, with the confirmed involvement of multi-focal sites. These included biopsy proven sites of the face and duodenum along with the radiographic involvement of the lungs, liver, and osseous tissue. We report this unique presentation of a rare malignancy and the treatment course with radiation, paclitaxel, and bevacizumab. We also discuss the implications of her co-morbid liver cirrhosis and gastric antral vascular ectasia (GAVE) in terms of its influence on the development of the angiosarcoma and treatment response.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6351118 | PMC |
| http://dx.doi.org/10.7759/cureus.3650 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Lymphadenectomy in the treatment of sarcomas - indications and technique.
Oncol Rev
December 2024
Department of Soft Tissue/Bone Sarcoma and Melanoma, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland.
Sarcomas are a rare type of malignancy with limited treatment options so far. This analysis aimed to describe the impact of lymphadenectomy on treating sarcoma patients. Sarcomas characterized by lymphatic spread are rare.
View Article and Find Full Text PDFSynchronous primary breast angiosarcoma with invasive ductal carcinoma.
Breast Dis
September 2024
Department of Medical Oncology, Habib Bourguiba Hospital University of Sfax, Sfax, Tunisia.
Primary angiosarcoma (PAS) of the breast is an extremely uncommon variant of breast malignancies. Highly aggressiveness and dismal prognosis characterize this endothelial neoplasm. We report here an unusual case of PAS of the breast occurring in a 46-year-old woman associated with concurrent bilateral invasive ductal carcinoma and ovarian metastases.
View Article and Find Full Text PDFGrowth Rate and Outcomes in Locally Recurrent Extremity and Truncal Soft Tissue Sarcoma.
JAMA Netw Open
September 2024
Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York.
Article Synopsis
- Improved prognostic tools are essential for patients with locally recurrent soft tissue sarcoma (STS), prompting an investigation into how the average local recurrence growth rate influences patient outcomes after resection.
- The study analyzed data from 253 patients, revealing a 5-year cumulative incidence of disease-specific death (DSD) at 29%, with several factors like LR growth rate, age, and tumor characteristics significantly impacting outcomes.
- Key findings outlined that faster local recurrence growth and other specific tumor traits were associated with a higher risk of DSD, highlighting the need for precise tools to assess patient prognosis effectively.
Synchronous multiple primary malignancies or transdifferentiation?-A diagnostic challenge in a case of Xeroderma pigmentosum.
Indian J Pathol Microbiol
September 2024
Department of Pathology, Dr. Chandramma Dayananda Sagar Institute of Medical Education and Research, Dayananda Sagar University, Ramanagara, Karnataka, India.
Article Synopsis
- The case discusses synchronous tumors in a patient with Xeroderma pigmentosum, highlighting a melanoma on the scalp and an angiosarcoma on the cheek that appeared similar histologically.
- Melanin presence in the angiosarcoma raised concerns about a potential transdifferentiation from melanoma, but immunohistochemistry tests ruled this out.
- The study emphasizes how the unique morphology of the tumors helped clarify the diagnosis, as non-cutaneous cancers are rare in patients with Xeroderma pigmentosum.
Synchronous Double Primary Angiosarcoma Originating from the Stomach and Rectum: A Case Report and a Literature Review.
Arch Iran Med
March 2024
Başakşehir Çam and Sakura City Hospital, Department of Gastroenterology, 34480 Istanbul, Turkey.
Angiosarcomas originating from the gastrointestinal tract are rare but highly aggressive tumors with poor prognosis. These tumors can be misdiagnosed as benign and malignant gastrointestinal tract lesions. The definitive histological diagnosis of angiosarcomasis made by pathologists based on immunohistochemical analysis demonstrating cluster of differentiation 31 (CD31), factor VIII-related antigen (FVIIIRAg), erythroblast transformation specific related gene (ERG), and cluster of differentiation 34 (CD34).
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!